Export restrictions lifted on HCQ APIs, formulations by Government

The export restrictions has been lifted by the government on active pharmaceutical ingredients (API) and formulations of hydroxychloroquine (HCQ).

“Department of Pharmaceuticals has approved the lifting of ban on export of hydroxychloroquine APIs as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market. DGFT has been asked to issue formal notification in this regard.” Sadananda Gowda, Minister of Chemicals and Fertilisers told in a tweet.

As per the comments in her tweet, some appreciated the move while others expressed concerns over the increasing price of HCQ APIs and its impact on finished formulations
Sahil Munjal, Vice Chairman, Pharmexcil said, “We welcome the move, it is good news for hydroxychloroquine exporters and manufacturers. With this move, the industry also expects stability in the API prices of hydroxychloroquine.”

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert